Cargando…
Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome
Hypertension is common in hemolytic uremic syndrome (HUS) and often difficult to control. Local renin-angiotensin activation is believed to be an important part of thrombotic microangiopathy, leading to a vicious cycle of progressive renal injury and intractable hypertension. This has been demonstra...
Autores principales: | Raghunathan, V., Sethi, S. K., Dragon-Durey, M. A., Dhaliwal, M., Raina, R., Jha, P., Bansal, S. B., Kher, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358156/ https://www.ncbi.nlm.nih.gov/pubmed/28356668 http://dx.doi.org/10.4103/0971-4065.181462 |
Ejemplares similares
-
Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced
por: Sethi, S. K., et al.
Publicado: (2017) -
Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021) -
A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome
por: Omiya, Chiaki, et al.
Publicado: (2023) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)